CGRP Plasma Levels Decrease in Classical Trigeminal Neuralgia Patients Treated with Botulinum Toxin Type A: A Pilot Study.

Zhang, Yi; Lian, Yajun; Zhang, Haifeng; Xie, Nanchang; Chen, Yuan

Zhang, Yi; Lian, Yajun; Zhang, Haifeng; Xie, Nanchang; Chen, Yuan.

Afiliación

Zhang Y; Department of Neurology, Zhengzhou University First Affiliated Hospital, Henan, China.
Lian Y; Department of Neurology, Zhengzhou University First Affiliated Hospital, Henan, China.
Zhang H; Department of Neurology, Zhengzhou University First Affiliated Hospital, Henan, China.
Xie N; Department of Neurology, Zhengzhou University First Affiliated Hospital, Henan, China.
Chen Y; Department of Neurology, Zhengzhou University First Affiliated Hospital, Henan, China.

Pain Med ; 21(8): 1611-1615, 2020 08 01.

Article en En | MEDLINE | ID: mdl-32167549

Asunto(s)

Toxinas Botulínicas Tipo A; Neuralgia del Trigémino; Péptido Relacionado con Gen de Calcitonina; Humanos; Proyectos Piloto; Resultado del Tratamiento; Neuralgia del Trigémino/tratamiento farmacológico

Palabras clave

Analgesic Mechanism; Neurogenic Inflammation; Neuropeptides; Trigeminal Ganglia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuralgia del Trigémino / Toxinas Botulínicas Tipo A Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pain Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google